Vimarsana
Biggest News Aggregation in the World

Page 10 - Led Research Collaborative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Led Research Collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Led Research Collaborative Today - Breaking & Trending Today

Does the microbiome hold the key to chronic fatigue? - Vimarsana News

Does the microbiome hold the key to chronic fatigue?

Often dismissed by the medical establishment, people with complex illnesses such as ME and long Covid are taking the hunt for treatments into their own hands

From over 200 to 12 symptoms: Study sharpens definition of "Long Covid" - Vimarsana News

From over 200 to 12 symptoms: Study sharpens definition of "Long Covid"

A study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health, home to the effort’s Clinical Science Core (CSC), provides an expanded working definition of long Covid.

For covid long-haulers, the pandemic is far from over - Vimarsana News

For covid long-haulers, the pandemic is far from over

The end of the coronavirus public health emergency has left long-covid patients fearful they will be forgotten.

Source: adn.com
Q&A with Lisa McCorkell, Long COVID researcher and patient - New York Amsterdam News - Vimarsana News

Q&A with Lisa McCorkell, Long COVID researcher and patient - New York Amsterdam News

The Amsterdam News interviewed Lisa McCorkell, one of the co-founders of the Patient-Led Research Collaborative, who has a background in public policy, public health advocacy, and research.

RECOVER study: An important step toward defining long COVID - Vimarsana News

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.